Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Therapeutic Potentials of Curcumin in the Treatment of Glioblstoma Publisher Pubmed



Shabaninejad Z1, 2 ; Pourhanifeh MH3 ; Movahedpour A4, 5 ; Mottaghi R6 ; Nickdasti A7 ; Mortezapour E7 ; Shafiee A8 ; Hajighadimi S8 ; Moradizarmehri S8 ; Sadeghian M9 ; Mousavi SM10 ; Mirzaei H7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
  2. 2. Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Halal Research Center of IRI, FDA, Tehran, Iran
  4. 4. Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences Shiraz, Iran
  5. 5. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Department of Oral and Maxillofacial Surgery, Kashan University of Medical Sciences, Kashan, Iran
  7. 7. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, I.R, Iran
  8. 8. Division of General Internal Medicine, Toronto General Hospital, Toronto, Canada
  9. 9. Orthopedic Surgeon Fellowship of Spine Surgery, Sasan General Hospital, Tehran, Iran
  10. 10. Department of Neuroscience, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: European Journal of Medicinal Chemistry Published:2020


Abstract

Glioblastoma multiforme (GBM), a greatly aggressive malignancy of the brain, is correlated with a poor prognosis and low rate of survival. Up to now, chemotherapy and radiation therapy after surgical approaches have been the treatments increasing the survival rates. The low efficacy of mentioned therapies as well as their side-effects has forced researchers to explore an appropriate alternative or complementary treatment for glioblastoma. In experimental models, it has been shown that curcumin has therapeutic potentials to fight against GBM. Given that curcumin has pharmacological effects against cancer stem cells, as major causes of resistance to therapy in glioblastoma cells. Moreover, it has been showed that curcumin exerts its therapeutic effects on GBM cells via affecting on apoptosis, oxidant system, and inflammatory pathways. Curcumin would possess a synergistic impact with chemotherapeutic agents. Herein, we summarized the current findings on curcumin as therapeutic agent in the treatment of GBM. © 2020 Elsevier Masson SAS
Other Related Docs
12. Curcuminoids, Recent Advances in Natural Products Analysis (2020)
21. Micrornas-Based Imaging Techniques in Cancer Diagnosis and Therapy, Journal of Cellular Biochemistry (2017)
22. Anti-Tumor Effects of Curcumin and Abt-737 in Combination Therapy for Glioblastoma in Vivo, International Journal of Molecular and Cellular Medicine (2025)
25. Teeth-Derived Stem Cells: A Source for Cell Therapy, Journal of Cellular Physiology (2019)
28. Micrornas and Exosomes: Cardiac Stem Cells in Heart Diseases, Pathology Research and Practice (2022)
33. Autophagy in Cancers Including Brain Tumors: Role of Micrornas, Cell Communication and Signaling (2020)
34. Circular Rnas: New Genetic Tools in Melanoma, Biomarkers in Medicine (2020)
45. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
47. Microrna Biosensors for Detection of Glioblastoma, Clinica Chimica Acta (2024)